RespireRx Pharmaceuticals Inc (RSPI): Aiming, According to the press release,...

Reply Private New

Replies (3) Next 10 Prev Next

Send PM Follow Ignore

Followers	87
Posts	33471
Boards Moderated	87
Alias Born	03/22/2005

gfp927z

Re: Aiming4 post# 18111

Wednesday, 06/18/2008 9:59:19 AM

Wednesday, June 18, 2008 9:59:19 AM

Aiming, According to the press release, it was the DSMB that recommended adding more patients. There were no safety issues. As Myostrain said, more subjects will make for a better statistical analysis. Once they confirmed there were no safety issues in the interim analysis, they could safely allow more subjects into the trial.

Hopefully Neuro will chime in soon with his take. He's probably at the BIO 2008 conference right now.

Keep Last Read

Replies (3) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM